Full Paper
such as tmeda, NH4PF6, and solvents were obtained from Spectro
Chem, India. The reagents were used as received unless specified
H, -CH3) ppm. 13C NMR (100 MHz, [D6]DMSO, 300 K): δ = 157.97,
151.85, 150.94, 140.24, 137.13, 131.04, 127.50, 112.92, 104.33, 65.56,
otherwise. cis-[Pd(tmeda)Cl2] and cis-[Pd(tmeda)(NO3)2] were pre- 62.65, 50.96, 50.73 ppm. MS (ESI): m/z = 284, [1a-2NO3]2+
.
pared according to literature procedures.[19] The cis-protected PdII
[Pd(tmeda)(L)](BF4)2 (1b): The ligand L (0.0175 g, 0.05 mmol) was
added to a solution of [Pd(tmeda)](BF4)2 (0.0198 g, 0.05 mmol) in
acetonitrile (5 mL). The reaction mixture was stirred at room tem-
perature for 1 h to obtain a clear yellow solution. The resulting
solution was poured into a watch-glass and subsequently evapo-
rated at room temperature over a period of 6 h to obtain a yellow
solid. The solid was washed with acetone (2 × 2 mL) and dried un-
der vacuum to afford complex 1b (0.0290 g, isolated yield 78 %).
–
components, that is, cis-[Pd(tmeda)(Y)2] (Y
=
NO3
,
BF4–, PF6–, CF3SO3–, and ClO4–) were prepared by the reaction of
cis-[Pd(tmeda)Cl2] with AgY (see Supporting Information). The deu-
teriated solvents CDCl3 and [D6]DMSO were obtained from Sigma–
Aldrich. NMR spectra were recorded in CDCl3 and [D6]DMSO at
room temperature with Bruker AV400 and AV500 spectrometers
(400 and 500 MHz for 1H NMR; 100 and 125 MHz for 13C NMR).
Chemical shifts are reported in ppm relative to residual solvent pro-
1
The H NMR spectrum of compound 1b is comparable with that of
1
tons (δ = 7.26 ppm for CDCl3 in H NMR and δ = 77.16 ppm in 13C
compound 1a.
NMR; δ = 2.50 ppm for [D6]DMSO in 1H NMR and δ = 39.43 ppm in
13C NMR). MS (ESI) spectra were recorded with Agilent Q-TOF and
Micromass Q-TOF spectrometers. Single-crystal X-ray diffraction
analysis was carried out by using a Bruker APEX II-CCD XRD diffrac-
tometer. CHN analysis was performed with a Perkin–Elmer 2400
series CHNS/O Analyzer. Melting points were determined using a
CINTEX apparatus.
[Pd(tmeda)(L)](Y)2 (1c–1e): Complexes [Pd(tmeda)(L)](Y)2 (1c–1e;
Y = PF6–, CF3SO3–, and ClO4–, respectively) were prepared in a simi-
lar manner as described for 1b using the appropriate cis-protected
PdII component [Pd(tmeda)](Y)2 (see the Supporting Information).
[Pd(L)2](NO3)2 (3a): The ligand L (0.0209 g, 0.06 mmol) was added
to a solution of Pd(NO3)2 (0.0069 g, 0.03 mmol) in DMSO (3 mL).
The reaction mixture was stirred at room temperature for 10 min.
Subsequently, the addition of ethyl acetate (10 mL) to the resulting
solution led to a white solid precipitate, which was separated by
centrifugation. The solid was washed with acetonitrile (2 × 2 mL)
and dried under vacuum to afford complex 3a (0.0222 g, isolated
yield 80 %), m.p. 232 °C (decomp.). 1H NMR (500 MHz, [D6]DMSO,
300 K): δ = 9.66 (s, 4 H, Ha), 9.39 (d, J = 1.0 Hz, 4 H, Hb), 9.38 (s, 4
H, Hf), 8.86 (s, 2 H, Hg), 8.09 (d, J = 8.0 Hz, 4 H, Hd), 7.73 (dd, J =
5.0, 5.0 Hz, 4 H, Hc), 5.43 (s, 8 H, He) ppm. 13C NMR (125 MHz,
[D6]DMSO, 300 K): δ = 162.96, 154.27, 151.20, 150.91, 140.84, 139.77,
136.16, 127.46, 125.45, 64.77 ppm. MS (ESI): m/z = 402.15 [3a –
Synthesis of the Ligand (L): A 100 mL round-bottomed flask was
charged with pyridine-3,5-dicarboxylic acid (0.618 g, 3.7 mmol) and
SOCl2 (20 mL) and the mixture was heated at reflux under nitrogen
for 48 h. The excess SOCl2 was removed by distillation under re-
duced pressure to give a pale-yellow solid. This solid was sus-
pended in dry dichloromethane (20 mL) and 3-hydroxymethylpyr-
idine (0.807 g, 7.4 mmol) was added followed by the dropwise addi-
tion of triethylamine (1 mL). The suspension was then heated at
reflux for 4 h, after which the suspension was cooled to room tem-
perature. A saturated aqueous solution of sodium hydrogen carb-
onate (20 mL) was then added. The organic layer was separated
and then evaporated to dryness under reduced pressure. The crude
product was purified by silica gel column chromatography prepared
by using hexane. The column was eluted with EtOAc/hexane (1:1)
to remove less polar impurities. Subsequently, elution with DCM/
acetone (3:7) afforded the product as a white solid (0.954 g, isolated
yield 74 %) after evaporation of the solvent and drying under vac-
uum, m.p. 121 °C. 1H NMR (500 MHz, CDCl3): δ = 9.38 (s, 2 H, Hf),
8.86 (s, 1 H, Hg), 8.79 (s, 2 H, Ha), 8.63 (d, J = 2.0 Hz, 2 H, Hb), 7.81
(d, J = 2.0 Hz, 2 H, Hd), 7.36–7.34 (dd, J = 0.5, 0.5 Hz, 2 H, Hc), 5.43
(s, 4 H, He) ppm. 13C NMR (125 MHz, CDCl3, 300 K): δ = 164.20,
154.65, 150.15, 149.98, 138.35, 136.58, 131.00, 125.86, 123.82,
65.12 ppm. 1H NMR (400 MHz, [D6]DMSO): δ = 9.33 (s, 2 H, Hf), 8.72
(s, 2 H, Ha), 8.68 (s, 1 H, Hg), 8.58 (d, J = 3.2 Hz, 2 H, Hb), 7.94 (d, J =
7.6 Hz, 2 H, Hd), 7.46–7.43 (dd, J = 4.8, 4.8 Hz, 2 H, Hc), 5.46 (s, 4 H,
He) ppm. 13C NMR(100 MHz, [D6]DMSO, 300 K): δ = 163.75, 153.79,
149.50, 149.41, 137.28, 136.16, 131.27, 125.59, 123.66, 64.70 ppm.
MS (ESI): m/z = 350.11 [M + H]+. C19H15N3O4 (349.3): calcd. C 65.32,
H 4.33, N 12.03; found C 64.37, H 4.38, N 11.77.
2NO3]2+
.
[Pd(L)2](BF4)2 (3b): A sample of Pd(BF4)2 was prepared in DMSO
(3 mL) by stirring a mixture of PdI2 (0.0108 g, 0.03 mmol) and AgBF4
(0.0116 g, 0.06 mmol) at 90 °C for 30 min. The precipitated AgI was
separated by centrifugation and the supernatant was transferred by
using a syringe. The ligand L (0.0209 g, 0.06 mmol) was added to
the solution of Pd(BF4)2 (0.0084 g, 0.03 mmol) prepared in DMSO
(3 mL), and the reaction mixture was stirred at room temperature
for 10 min. Subsequently, the addition of ethyl acetate (10 mL) to
the resulting solution led to a white solid precipitate, which was
separated by centrifugation. The solid was washed with acetonitrile
(2 × 10 mL) and dried under vacuum to afford complex 3b
(0.0241 g, isolated yield 82 %). The 1H NMR spectrum of compound
3b is similar to that of compound 3a.
–
[Pd(L)2](Y)2 (3c–3e): Complexes [Pd(L)2](Y)2 (3c–3e; Y = PF6
,
CF3SO3–, and ClO4–, respectively) were prepared in a similar manner
as described for 3b using the appropriate silver salt (see the Sup-
porting Information).
Synthesis of the Complexes
[Pd(tmeda)(L)](NO3)2 (1a): The ligand L (0.0175 g, 0.05 mmol) was
added to a solution of cis-[Pd(tmeda)(NO3)2] (0.0173 g, 0.05 mmol)
in acetonitrile (5 mL). The reaction mixture was stirred at room tem-
perature for 1 h to obtain a clear yellow solution. The resulting
[(NO3)2⊂Pd3(L)4](NO3)4 (4a): The ligand L (0.0139 g, 0.04 mmol)
was added to a solution of Pd(NO3)2 (0.0069 g, 0.03 mmol) in DMSO
(3 mL). The reaction mixture was stirred at 90 °C for 2 h. Subse-
quently, the addition of ethyl acetate (10 mL) to the resulting solu-
solution was poured into a watch-glass and then evaporated at tion led to a white solid precipitate, which was separated by centrif-
room temperature by allowing to stand for 6 h to obtain a yellow ugation. The solid was washed with acetonitrile (2 × 2 mL) and
solid. The solid was washed with acetone (2 × 2 mL) and dried un-
dried under vacuum to afford complex 4a (0.0462 g, isolated yield
74 %), m.p. 300 °C (decomp.). H NMR (500 MHz, [D6]DMSO, 300 K):
δ = 10.63 (s, 8 H, Hf), 9.88 (s, 8 H, Ha), 9.23 (d, J = 6.0 Hz, 8 H, Hb),
8.85 (s, 4 H, Hg), 8.12 (d, J = 8.0 Hz, 8 H, Hd), 7.79–7.76 (dd, J = 6.0,
6.0 Hz, 8 H, Hc), 5.51 (s, 16 H, He) ppm. 13C NMR (125 MHz,
[D6]DMSO, 300 K): δ = 162.47, 157.07, 151.13, 149.43, 142.97, 139.62,
1
der vacuum to afford complex 1a (0.0295 g, isolated yield 85 %),
1
m.p. 274 °C. H NMR (400 MHz, [D6]DMSO, 300 K): δ = 9.59 (s, 2 H,
Ha), 9.37 (s, 2 H, Hf), 9.31 (d, J = 5.2 Hz, 2 H, Hb), 8.83 (s, 1 H, Hg),8.17
(d, J = 8.0 Hz, 2 H, Hd), 7.79–7.76 (m, J = 6.0, 5.6 Hz, 2 H, Hc), 5.65–
5.27 (dd, J = 12.4, 12.8 Hz, 4 H, He), 2.96 (s, 4 H, -CH2-), 2.44 (s, 12
Eur. J. Inorg. Chem. 2016, 2816–2827
2825
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim